
Our coolest superpower: Seeing all the atoms
Wouldn't it be great if we could just see all the atoms of all the molecules, any time we wanted?
If we were able to sample something — anything — and just tell what it's made of? Where all its atoms were? Which ones were connected or ready to react?
In about the span of a century, scientists have learned more about molecules and their components than we ever thought possible. In some cases, we can already pick up a bit of dust or a tiny droplet and see where the atoms of its resident molecules are. Or we can calculate predicted structures that are so accurate they can be used to predict function.
In old comic books, this kind of X-ray vision was the stuff of superheroes. Someday, in the not-too-distant future, we might all have it.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.
Join us for a glimpse into the challenges and opportunities of building that future, so we can all scrutinize, predict, build, target and react to all the molecules.
Keywords: Structure, cryo-electron microscopy, microcrystal electron diffraction, alpha fold, tomography, artificial intelligence.
Who should attend: Absolutely everyone should attend. Who doesn't want a superpower?
Theme song: “Mosaic” by Art Blakey and the Jazz Messengers
This session is literally powered by electrons and photons.
New frontiers in structural biology
The rise of molecular assemblies

Chair: Rebecca Vorhees
Sarah Shahmoradian, University of Texas Southwestern Medical Center
Lorena Saelices, University of Texas Southwestern Medical Center
New approaches enabling structural science
Chair: Jose Rodriguez
Roger Castells–Graells, University of California, Los Angeles
Hosea Nelson, California Institute of Technology
Hong Zhou, University of California, Los Angeles
Seeing the chemistry of life
Chair: Hosea Nelson
Lindsey R. F. Backman, Whitehead Institute for Biomedical Research
Douglas Rees, California Institute of Technology
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.